Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.077 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |